| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |